Saudi­Vax and Mil­li­pore­Sig­ma team up to man­u­fac­ture do­mes­tic vac­cine for the Ara­bi­an penin­su­la

As Sau­di Ara­bia works to get its do­mes­ti­cal­ly-pro­duced vac­cines in­to the arms of res­i­dents, it’s en­list­ed the help of Mer­ck KGaA, Darm­stadt, Ger­many to take on man­u­fac­tur­ing du­ties.

Mil­li­pore­Sig­ma, the US and Cana­di­an life sci­ence di­vi­sion of Mer­ck KGaA, Darm­stadt, Ger­many, and Saudi­Vax will first con­cep­tu­al­ize the process and de­ter­mine the equip­ment need­ed be­fore fit­ting out the fa­cil­i­ty and work­ing out process de­vel­op­ment. Saudi­Vax em­ploy­ees will head to France to train at Mer­ck’s end-to-end GMP site in Mar­tillac, and its M Lab Col­lab­o­ra­tion Cen­ter in Mosheim.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER